ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 732830 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 732830; 2) Community: the network communities that were significantly associated with the response to NSC 732830; 3) Molecule: the relationships between components within communities and NSC 732830; 4) MDR: the compounds that were significantly associated with the NSC 732830.

NSC Compound Enrichment Correlation
NSC 680934 Null 0.0186186224062459 0.1256966
NSC 688228 Null 0.0186186224062459 0.20536224
NSC 701023 Aceanthryleno[1,2-b]quinoxaline, 12-nitro- 0.0186186224062459 0.20902186
NSC 715481 Null 0.0186186224062459 0.23276222
NSC 717468 Null 0.0186186224062459 0.20472674
NSC 724783 [1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 0.0186186224062459 0.28547391
NSC 728078 2-carboxy-(2'-furyl)-7-chloro-3-trifluoromethylquinoxaline 1,4-dioxide 0.0186186224062459 0.31338439
NSC 731701 1[(4-n-butyloxyCarbonyl)piperazine-1-yl]diazene-1-ium-1,2-di olate 0.0186186224062459 -0.10814552
NSC 114512 Null 0.0220039422291538 0.52074669
NSC 269721 Androstan-3-one, 17-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (5.alpha.,17.beta.)- 0.0220039422291538 0.29538439
Total:75  Current:35    [First] [Prev] [Next] [Last]